Research/art/teacher profile of a person
Name and surname:
PharmDr. Gabriela Greifová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Greifová
I.2 - Name
Gabriela
I.3 - Degrees
PharmDr., PhD.
I.4 - Year of birth
1988
I.5 - Name of the workplace
Faculty of Pharmacy Comenius University Bratislava
I.6 - Address of the workplace
Odbojárov 10, 832 32 Bratislava
I.7 - Position
assisstant professor
I.8 - E-mail address
greifova1@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.fpharm.uniba.sk/greifova-gabriela/
I.10 - Name of the study field in which a person works at the university
Pharmacy
I.11 - ORCID iD
57193905140

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy Comenius University Bratislava
II.b - Year
2014
II.c - Study field and programme
Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy Comenius University Bratislava
II.b - Year
2019
II.c - Study field and programme
Pharmaceutical Chemistry
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
assisstant professor Faculty of Pharmacy, Comenius University Bratislava 2019 -
assisstant Faculty of Pharmacy, Comenius University Bratislava 2018-2019

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
member of Czechoslovak society for microbiology CZECHOSLOVAK SOCIETY FOR MICROBIOLOGY 2014
FEMS Summer School on Microbiology Education FEMS 2022

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
3
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
11
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
15
VI.1.b - Over the last six years
8
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
4
VI.1.b - Over the last six years
2
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
73
VI.1.b - Over the last six years
70
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
1
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Greifová G, Májeková H, Greif G, Body P, Greifová M, Dubničková M. Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. Folia Microbiol (Praha). 2017 Nov;62(6):515-524. doi: 10.1007/s12223-017-0524-9

2

Greifová G, Body P, Greif G, Greifová M, Dubničková M. Human phagocytic cell response to histamine derived from potential probiotic strains of Lactobacillus reuteri. Immunobiology. 2018 Nov;223(11):618-626. doi: 10.1016/j.imbio.2018.07.007

3

Body P, Greif G, Greifová G, Sliacká M, Greifová M. Effects of cultivation media and NaCl concentration on the growth kinetics and biogenic amines production of Lactobacillus reuteri. Czech J. Food Sci. 2021; 39:09–16. https://doi.org/10.17221/190/2020-CJFS.

4

Drobná E, Greifová G, Dubničková M. Praktické cvičenia z mikrobiológie pre farmaceutov. Bratislava : Faculty of Pharmacy UK , 2021. ISBN 978-80-223-5123-2

5

Dudík B, Kiňová Sepová H, Greifová G, Bilka F, Bílková A. Next generation probiotics: an overview of the most promising candidates. Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):48-56. English.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Greifová G, Májeková H, Greif G, Body P, Greifová M, Dubničková M. Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. Folia Microbiol (Praha). 2017 Nov;62(6):515-524. doi: 10.1007/s12223-017-0524-9

2

Greifová G, Body P, Greif G, Greifová M, Dubničková M. Human phagocytic cell response to histamine derived from potential probiotic strains of Lactobacillus reuteri. Immunobiology. 2018 Nov;223(11):618-626. doi: 10.1016/j.imbio.2018.07.007

3

Body P, Greif G, Greifová G, Sliacká M, Greifová M. Effects of cultivation media and NaCl concentration on the growth kinetics and biogenic amines production of Lactobacillus reuteri. Czech J. Food Sci. 2021; 39:09–16. https://doi.org/10.17221/190/2020-CJFS.

4

Drobná E, Greifová G, Dubničková M. Praktické cvičenia z mikrobiológie pre farmaceutov. Bratislava : Faculty of Pharmacy UK , 2021. ISBN 978-80-223-5123-2

5

Dudík B, Kiňová Sepová H, Greifová G, Bilka F, Bílková A. Next generation probiotics: an overview of the most promising candidates. Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):48-56. English.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Greifová G, Májeková H, Greif G, Body P, Greifová M, Dubničková M. Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. Folia Microbiol (Praha). 2017 Nov;62(6):515-524. doi: 10.1007/s12223-017-0524-9

Citations in Web of Science database:

  1. Li W, He H, Li S, Jiang B, Liu C, Huang Y. Effects of dietary Lactobacillus reuteri on antimicrobial activity, antioxidant capacity, non-specific immune response, and resistance to Streptococcus agalactiae infection of the Nile tilapia (Oreochromis niloticus). Aquaculture Reports. 2024;35:N°101976. 10.1016/j.aqrep.2024.101976
  2. Mbaye B, Wasfy RM, Alou MT, Borentain P, Gerolami R, Dufour JC, Million M. A catalog of ethanol-producing microbes in humans. Future Microbiol. 2024;19(8):697-714. doi: 10.2217/fmb-2023-0250.
  3. Shaposhnikov LA, Tishkov VI, Pometun AA. Lactobacilli and Klebsiella: Two Opposites in the Fight for Human Health. Biochemistry (Mosc). 2024;89(Suppl 1):S71-S89. doi: 10.1134/S0006297924140050.
  4. Abdel Ghany Elrahmany HM, Ali A, El-Batawy OI, Khedr M, Hassan MA. Genetic engineering of UV-mutated Bifidobacterium longum and Lactobacillus acidophilus in relation to folic acid and Anti-inflammatory productivity. Egyptian Journal of Chemistry. 2023;66(13), 983-992. doi: 10.21608/ejchem.2023.199128.7711
  5. [o1]El-Aidie SAM, Mabrouk AM, Abd-Elgawad AR, El- Garhi HM. Physicochemical, textural and organoleptic properties of functional processed cheese manufactured from ultrafiltered milk. Biocatalysis and Agricultural Biotechnology,. 2023;51:102798, doi: 10.1016/j.bcab.2023.102798
  6. [o1]Wu Y, Cao X, Du H, Guo X, Han Y, McClements DJ, Decker E, Xing B, Xiao H. Adverse effects of titanium dioxide nanoparticles on beneficial gut bacteria and host health based on untargeted metabolomics analysis. Environmental Research. 2023 Jul 1;228:115921. doi: 10.1016/j.envres.2023.115921
  7. [o1]Rodrigues FJ, Cedran MF, Bicas JL, Sato HH.Inhibitory effect of reuterin-producing Limosilactobacillus reuteri and edible alginate-konjac gum film against foodborne pathogens and spoilage microorganisms. Food Bioscience. 2023;52:102443. doi: 10.1016/j.fbio.2023.102443.
  8. [o1]Jiang J, Li K, Xiao Y, Zhong A, Tang J, Duan Y, Li Z. Limosilactobacillus reuteri Regulating Intestinal Function: A Review. Fermentation. 2023; 9(1):19. https://doi.org/10.3390/fermentation9010019
  9. [o1]Lee HL, Kim JM, Moon JH, Kim MJ, Jeong HR, Go MJ, Kim HJ, Eo HJ, Lee U, Heo HJ. Anti-Amnesic Effect of Synbiotic Supplementation Containing Corni fructus and Limosilactobacillus reuteri in DSS-Induced Colitis Mice. International Journal of Molecular Sciences. 2022 Dec 21;24(1):90. doi: 10.3390/ijms24010090.
  10. [o1]Ali MS, Lee EB, Quah Y, Birhanu BT, Suk K, Lim SK, Park SC. Heat-killed Limosilactobacillus reuteri PSC102 Ameliorates Impaired Immunity in Cyclophosphamide-induced Immunosuppressed Mice. Frontiers in Microbiology. 2022;13:820838. doi: 10.3389/fmicb.2022.820838. 
  11. [o1]Wang X, Ji Y, Qiu C, Zhang H, Bi L, Xi H, Lei L, Liu B, Han W, Gu J. A phage cocktail combined with the enteric probiotic Lactobacillus reuteri ameliorated mouse colitis caused by S. typhimurium. Food and Function. 2022;13 (16):8509-8523. doi: 10.1039/D2FO00699E
  12. [o1]Zhang S, Zhu J. Untargeted Metabolomics Sensitively Differentiates Gut Bacterial Species in Single Culture and Co-Culture Systems. ACS Omega. 2022;7(17):14643-14652. doi: 10.1021/acsomega.1c07114.
  13. [o1]Yang Z, Zhu X, Wen A, Qin L. Development of probiotics beverage using cereal enzymatic hydrolysate fermented with Limosilactobacillus reuteri. Food Science and Nutrition. 2022;10(9):3143-3153. doi: 10.1002/fsn3.2913. 
  14. [o1]Meruvu H, Harsa ST. Lactic acid bacteria: isolation-characterization approaches and industrial applications. Critical Reviews in Food Science and Nutrition. 2022 Mar 29:1-20. doi: 10.1080/10408398.2022.2054936.
  15. [o1]Abuqwider J, Altamimi M, Mauriello G. Limosilactobacillus reuteri in Health and Disease. Microorganisms. 2022;28;10(3):522. doi: 10.3390/microorganisms10030522. 
  16. [o1]Jang AY, Rod-In W, Monmai C, Sohn M, Kim TR, Jeon MG, Park WJ. Anti-inflammatory potential of Lactobacillus reuteri LM1071 via eicosanoid regulation in LPS-stimulated RAW264.7 cells. Journal of Applied Microbiology. 2022;133(1):67-75. doi: 10.1111/jam.15331.
  17. [o1] Zhu T, Mao J, Zhong Y, Huang C, Deng Z, Cui Y, Liu J, Wang H. L. reuteri ZJ617 inhibits inflammatory and autophagy signaling pathways in gut-liver axis in piglet induced by lipopolysaccharide. Journal of Animal Science and Biotechnology. 2021;12(1):110. doi: 10.1186/s40104-021-00624-9.
  18. [o1]Shazadi K, Ahmad SZ, Ahmad SS, Arshad N. In vivo prophylactic efficacy of Lactobacillus reuteri MT180537 against aerobic vaginitis. Microbial Pathogenesis. 2021;160:105197. doi: 10.1016/j.micpath.2021.105197
  19. [o1]Zhang C, Xia S, Zhang Y, Zhu S, Li H, Liu X. Identification of soybean peptides and their effect on the growth and metabolism of Limosilactobacillus reuteri LR08. Food Chemistry. 2022;369:130923. doi: 10.1016/j.foodchem.2021.130923.
  20. [o1]Luo H, Li P, Wang H, Roos S, Ji B, Nielsen J. Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri. BMC Biotechnology. 2021;21(1):46. doi: 10.1186/s12896-021-00702-w. 
  21. [o1]Rajanikar RV, Nataraj BH, Naithani H, Ali SA, Panjagari NR, Behare PV. Phenyllactic acid: A green compound for food biopreservation. Food Control. 2021;128:108184. doi: 10.1016/j.foodcont.2021.108184.
  22. [o1]Popovic M, Stojanovic M, Veličkovic Z, Kovačevic A, Miljkovic R, Mirkovic N, Marinkovic A. Characterization of potential probiotic strain, L. reuteri B2, and its microencapsulation using alginate-based biopolymers. International Journal of Biological Macromolecules. 2021;183:423-434. doi: 10.1016/j.ijbiomac.2021.04.177.
  23. [o1]Johari B, Maghsood F, Madanchi H, Moradi M, Kadivar M. Investigating the anti-inflammatory effects of high molecular weight secretions from Limosilactobacillus reuteri PTCC 1655 on LPS-stimulated PMA-differentiated THP-1 cells. Journal of Applied Microbiology. 2021;131(2):938-948. doi: 10.1111/jam.14984. 
  24. [o1]Soltani S, Couture F, Boutin Y, Ben Said L, Cashman-Kadri S, Subirade M, Biron E, Fliss I. In vitro investigation of gastrointestinal stability and toxicity of 3-hyrdoxypropionaldehyde (reuterin) produced by Lactobacillus reuteri. Toxicology Reports. 2021;8:740-746. doi: 10.1016/j.toxrep.2021.03.025.
  25. [o1]Zheng TX, Pu SL, Tan P, Du YC, Qian BL, Chen H, Fu WG, Huang MZ. Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease. Frontiers in Physiology. 2020;11:595382. doi: 10.3389/fphys.2020.595382.
  26. [o1]Maccelli A, Carradori S, Puca V, Sisto F, Lanuti P, Crestoni ME, Lasalvia A, Muraro R, Bysell H, Di Sotto A, Roos S, Grande R. Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by Lactobacillus reuteri DSM 17938. Microorganisms. 2020;8(11):1653. doi: 10.3390/microorganisms8111653. 
  27. [o1]Al-Balawi M, Morsy FM. Enterococcus faecalis Is a Better Competitor Than Other Lactic Acid Bacteria in the Initial Colonization of Colon of Healthy Newborn Babies at First Week of Their Life. Frontiers in Microbiology. 2020;11:2017. doi: 10.3389/fmicb.2020.02017.
  28. [o1]Knysh OV, Martynov AV. Lactobacillus reuteri cell-free extracts against antibiotic-resistant bacteria. Zaporozhye Medical Journal. 2020;22(4):547-553. doi: 10.14739/2310-1210.2020.4.208397
  29. [o1]Rama GR, Führ AJ, da Silva JABS, Gennari A, Giroldi M, Goettert MI, Volken de Souza CF. Encapsulation of Lactobacillus spp. using bovine and buffalo cheese whey and their application in orange juice. 3 Biotech. 2020;10(6):263. doi: 10.1007/s13205-020-02255-9.
  30. [o1]Dudík B, Kiňová Sepová H, Bilka F, Pašková Ľ, Bilková A. Mucin pre-cultivated Lactobacillus reuteri E shows enhanced adhesion and increases mucin expression in HT-29 cells. Antonie Van Leeuwenhoek. 2020;113(8):1191-1200. doi: 10.1007/s10482-020-01426-1. 
  31. [o1]Wang H, Zhou C, Huang J, Kuai X, Shao X. The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease. Am J Transl Res. 2020;12(5):1569-1583. 
  32. [o1]Knysh OV, Martynov AV. Potentiation of the Antimicrobial Effect of Lactobacillus Reuteri DSM 17938 Cell-free Extracts by Ascorbic Acid." Medicni Perspektivi. 2020;25(1):17-24. doi:10.26641/2307-0404.2020.1.200393.
  33. [o1]Geraldo BMC, Batalha MN, Milhan NVM, Rossoni RD, Scorzoni L, Anbinder AL. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis. J Periodontal Res. 2020;55(2):215-220. doi: 10.1111/jre.12704.
  34. [o1]Rama GR, Fuhr AJ, da Silva JABS, Gennari A, Giroldi M, Goettert MI, Volken de Souza CF. Potential applications of dairy whey for the production of lactic acid bacteria cultures. 3 Biotech. 2020;10(6):25-37. doi:10.1016/j.idairyj.2019.06.012
  35. [o1]Jiang P, Yang W, Jin Y, Huang H, Shi C, Jiang Y, Wang J, Kang Y, Wang C, Yang G. Lactobacillus reuteri protects mice against Salmonella typhimurium challenge by activating macrophages to produce nitric oxide. Microb Pathog. 2019;137:103754. doi: 10.1016/j.micpath.2019.103754. 
  36. [o1]Esposito F, Montuori P, Schettino M, Velotto S, Stasi T, Romano R, Cirillo T. Level of Biogenic Amines in Red and White Wines, Dietary Exposure, and Histamine-Mediated Symptoms upon Wine Ingestion. Molecules. 2019;24(19):3629. doi: 10.3390/molecules24193629.
  37. [o1]Khmaladze I, Butler É, Fabre S, Gillbro JM. Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin. Exp Dermatol. 2019;28(7):822-828. doi: 10.1111/exd.13950. 
  38. [o3]Knysh OV, Isayenko OY, Voyda YV, Kizimenko OO, Babych YM. Influence of cell-free extracts of Bifidobacterium bifidum and Lactobacillus reuteri on proliferation and biofilm formation by Escherichia coli and Pseudomonas aeruginosa. Regulatory Mechanisms in Biosystems. 2019;10(2):251-256. doi: 10.15421/021938
  39. [o1]Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in Human Health and Diseases. Front Microbiol. 2018;9:757. doi: 10.3389/fmicb.2018.00757. 

Citations in Scopus database:

  1. Tian W, Du T, He G, Tan T, Meng Y, Wei H. Intranasal administration of Lactobacillus reuteri TR02 attenuates Mycoplasma pneumoniae-induced lung inflammatory response in mice [鼻内滴入罗伊氏乳杆菌 TR02 减轻肺炎支原体诱导的小鼠肺部炎症损伤]. Chinese Journal of Microbiology and Immunology. 2024;44(4):323 – 32930. 10.3760/cma.j.cn112309-20230417-00099
  2. [o1]Zhu MZ, Xu HM, Liang YJ, Xu J, Yue NN, Zhang Y, Tian CM, Yao J, Wang LS, Nie YQ, Li DF. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion. J Nanobiotechnology. 2023;21(1):309. doi: 10.1186/s12951-023-02065
  3. [o1]Wang X, Wu M, Yu Q, Ma L, Yao D, Zhang L. Isolation and Identification of Lactiplantibacillus plantarum ST3.5 and Its Inhibitory Effect on Mold. Science and Technology of Food Industry. 2023;44(13):141−149. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022080334 
  4. [o1]Contaldo M. Use of Probiotics for Oral Candidiasis: State of the Art and Perspective. A Further Step Toward Personalized Medicine? Front Biosci (Elite Ed). 2023;15(1):6. doi: 10.31083/j.fbe1501006. 
  5. [o1]Shelby RD, Mar P, Janzow GE, Mashburn-Warren L, Tengberg N, Navarro JB, Allen JM, Wickham J, Wang Y, Bailey MT, Goodman SD, Besner GE. Antibacterial and anti-inflammatory effects of Lactobacillus reuteri in its biofilm state contribute to its beneficial effects in a rat model of experimental necrotizing enterocolitis. Journal of Pediatric Surgery. 2022;57(7):1382-1390. doi: 10.1016/j.jpedsurg.2021.09.001
  6. [o1]Jiang L, Zheng Z, Zhu S,,et al.Antibacterial effect of Lactobacillus plantarum, Lactobacillus rhamnosus and Lactobacillus reuteri on common pathogenic bacteria in hospital. Journal of Xinxiang Medical University,2022;39(6):501-506.doi:10.7683/xxyxyxb.2022.06.001
  7. [o1]CEN Q, PANG R, HU X, et al. New Developments in the Role of Lactobacillus Reuteri in Regulating Intestinal Barrier Function. Chinese General Practice, 2022;25(15): 1918-1922. DOI: 10.12114/j.issn.1007-9572.2021.02.123.
  8. [o1]Ledesma SC, Rubio MC, Aredes-Fernández P. Identification of histidine and tyrosine decarboxylating bacteria from Tucumán red wine, Journal of Wine Research, 2022;33:4, 235-245, DOI: 10.1080/09571264.2022.2143338
  9. [o3]Widyarman, A.S. - Pranoto, S. - Theodorea, C.F. - Bachtiar, E.W. - Bachtiar, B.M. - In: Scientific Dental Journal, Vol. 2, No. 2, 2018 ; s. 77
  10. [o1]Qian, G. - Ho, J.W.K. - In: Biophysical Reviews, Vol. 12, No. 4, 2020 ; s. 863 ; SCOPUS
  11. Yaseen, A.A. - Khashan, B.A. - Hasan, A.N. - Abedalhammed, H.S. - In: IOP Conference Series: Earth and Environmental
  12. [o3]Seijo, A. - María, M. - Ramón, S. - In: Investigation Clinica, Vol. 61, No. 3, 2020 ; s. 1168
  13. [o2]Karaffová, V. - Revajová, V. - Nemcová, R. - Ševčíková, Z. - Levkutová, M. - Levkut, M. - In: Folia Veterinaria, Vol. 64, No. 1, 2020 ; s. 47
  14. Ukraintsev, S.E. - Kornienko, E.A. - Kafarskaya, L.I. - Dubrovskaya, M.I. - In: Pediatriya - Zhurnal im G.N. Speranskogo, Vol. 99, No. 6, 2020 ; s. 171 ; SCOPUS

2

Greifová G, Body P, Greif G, Greifová M, Dubničková M. Human phagocytic cell response to histamine derived from potential probiotic strains of Lactobacillus reuteri. Immunobiology. 2018 Nov;223(11):618-626. doi: 10.1016/j.imbio.2018.07.007

Citations in Scopus database:

  1. [o1]Zhang B, Cai D, Lang Y, Lin X, Yang K, Shentu X, Yu X. A smartphone-integrated multi-model thermal immunochromatographic assay for sensitive detection of histamine in real samples. Sensors and Actuators B: Chemical. 2023;394:134474. doi: 10.1016/j.snb.2023.134474
  2. [o1]Shelby RD, Mar P, Janzow GE, Mashburn-Warren L, Tengberg N, Navarro JB, Allen JM, Wickham J, Wang Y, Bailey MT, Goodman SD, Besner GE. Antibacterial and anti-inflammatory effects of Lactobacillus reuteri in its biofilm state contribute to its beneficial effects in a rat model of experimental necrotizing enterocolitis. Journal of Pediatric Surgery. 2022;57(7):1382-1390. doi: 10.1016/j.jpedsurg.2021.09.001

Citations in Web of Sciences and Scopus databases:

  1. [o1]Fiorani M, Del Vecchio LE, Dargenio P, Kaitsas F, Rozera T, Porcari S, Gasbarrini A, Cammarota G, Ianiro G. Histamine-producing bacteria and their role in gastrointestinal disorders. Expert Review of Gastroenterology and Hepatology. 2023 Jul-Dec;17(7):709-718. doi: 10.1080/17474124.2023.2230865.
  2. [o1]Giri R, Sharma RK. Psychobiotics in diet: significance and applications of neuroactive and psychoactive microbial metabolites. Nutrition Reviews. 2022 Aug 8;80(9):2002-2016. doi: 10.1093/nutrit/nuac019.
  3. [o1]Averina OV, Poluektova EU, Marsova MV, Danilenko VN. Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as Representatives of the Human Gut Microbiota. Biomedicines. 2021 Sep 28;9(10):1340. doi: 10.3390/biomedicines9101340.
  4. [o1]Feng T, Wang J. Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes. 2020 Nov 9;12(1):1801944. doi: 10.1080/19490976.2020.1801944.
  5. [o1]Kaytez SK, Ocal R, Yumusak N, Celik H, Arslan N, Ibas M. Effect of probiotics in experimental otitis media with effusion. International Journal of Pediatric Otorhinolaryngology. 2020 May;132:109922. doi: 10.1016/j.ijporl.2020.109922.
3

Body P, Greif G, Greifová G, Sliacká M, Greifová M. Effects of cultivation media and NaCl concentration on the growth kinetics and biogenic amines production of Lactobacillus reuteri. Czech J. Food Sci. 2021; 39:09–16. https://doi.org/10.17221/190/2020-CJFS.

Citations in Web of Science and/or Scopus databases

  1. [o1]Meruvu H, Harsa ST. Lactic acid bacteria: isolation-characterization approaches and industrial applications. Critical Reviews in Food Science and Nutrition. 2022 Mar 29:1-20. doi: 10.1080/10408398.2022.2054936.
  2. [o1]Santamarina-García G, Amores G, López de Armentia E, Hernández I, Virto M. Relationship between the Dynamics of Gross Composition, Free Fatty Acids and Biogenic Amines, and Microbial Shifts during the Ripening of Raw Ewe Milk-Derived Idiazabal Cheese. Animals (Basel). 2022 Nov 21;12(22):3224. doi: 10.3390/ani12223224.
  3. [o1]Němečková I, Trešlová Š, Čížková H, Rambousková T, Forejt J, Švandrlík Z, Kružík V, Gabrovská D. Formation of sensory active substances during ripening of Dutch-type cheese with reduced salt content. Czech Journal of Food Sciences. 2023;41(2):103-110. DOI: 10.17221/239/2022-CJFS
  4. [o1]Ruiz-Rico M, Sánchez-Salom L, Fuentes A, Barat J. Inhibitory potential of natural antimicrobial compounds against histamine-forming lactic acid bacteria. Food Bioscience. 2024;61:104779. 10.1016/j.fbio.2024.104779.
  5. [o1]Ruiz-Rico M, Sánchez-Salom L, Fuentes A, Barat J. Inhibitory activity of natural antimicrobial compounds against histamine-forming bacterial isolates from cheese. LWT. 2024;203:116374. 10.1016/j.lwt.2024.116374.
  6. [o1]Pinchao YA, Serna-Cock L, Mora OO. Probiotic capacity of commensal lactic acid bacteria from the intestine of Guinea pigs (Cavia porcellus). Heliyon. 2024;10(8):e29431. doi: 10.1016/j.heliyon.2024.e29431.

4

Dudík B, Kiňová Sepová H, Greifová G, Bilka F, Bílková A. Next generation probiotics: an overview of the most promising candidates. Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):48-56. English.

  1. [o1]Hamamah S, Amin A, Al-Kassir AL, Chuang J, Covasa M. Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake. Nutrients. 2023 Jul 28;15(15):3365. doi: 10.3390/nu15153365;
  2. [o1]Salman MK, Mauriello G. Special Issue "Probiotics and Their Metabolism": Editorial. Microorganisms. 2023 Mar 8;11(3):687. doi: 10.3390/microorganisms11030687
  3. [o1]Shen C, Clawson JB, Simpson J, Kingsley K. Oral Prevalence of Akkermansia muciniphila Differs among Pediatric and Adult Orthodontic and Non-Orthodontic Patients. Microorganisms. 2023 Jan 1;11(1):112. doi: 10.3390/microorganisms11010112;
  4. [o1]Stastna M. The Role of Proteomics in Identification of Key Proteins of Bacterial Cells with Focus on Probiotic Bacteria. Int J Mol Sci. 2024;25(16):8564. doi: 10.3390/ijms25168564.
  5. [o2]Jung HY, Kim KW. An Evidence-Based Review of Probiotics and Prebiotics. Science insights. 2022;40(6):527-531. https://doi.org/10.15354/si.22.re055
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Grant Vedeckej rady Farmaceutickej fakulty UK v Bratislave: Synthesis and study of chosen derivatives of 1,3,5-triazine with amine acids as potential drugs with antioxidant and antiproliferative properties

  • vedúci projektu: PharmDr. Mária Bodnár Mikulová, PhD. a PharmDr. Gabriela Greifová, PhD.


2

VEGA 1/0527/21 Characteristics and use of microorganisms degrading biogenic amines as a possible solution to ensure health-safe fermented foods

  • co-investigator
  • Principal investigator: doc. Ing. Mária Greifová, PhD.
3

KEGA 064UK-4/2018: „Inovácia náplne praktických cvičení z predmetov Imunológia a Mikrobiológia a vypracovanie učebných textov“ (2018 - 2021)

  • co-investigator
  • Principal investigator: doc. Mgr. Andrea Bilková, PhD.


4

APVV-15-0308 „Molecular-pharmacological approaches to the treatment of innovative rheumatoid arthritis evaluated under experimental conditions in vivo and in vitro“ (2016 - 2020)

  • co-investigator
  • Principal investigator: PharmDr. Katarína Bauerová, PhD., DrSc.
5

FEMS Meeting Attendance Grant 2019

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Member of Czechoslovak Society for Microbiology Czechoslovak Society for Microbiology 2014-

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Faculté de Pharmacie, Université Paris Descartes Faculté de Pharmacie, 4 l´ Avenue de l´Observatoire, 75006 Paris, France 2012-2013 (10 months) Erasmus mobility

IX. - Other relevant facts

Date of last update
2025-01-28